Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

RARE PHOTOS: 3 - The Real Truth

'FFXIV's latest cameo hints at the return of a classic Final Fantasy villain

FFXIV's latest patch introduces some massive revelations for where the story could go, and a classic Final Fantasy villain might be the key.

Inverse

Take Advantage of These 5 'Strong Buy' Stocks Down More Than 10% YTD

Amid deepening supply disruptions and record-high inflation, expected aggressive federal interest rate increases, and the resurgence of COVID-19 cases have been driving market volatility. However, we think quality stocks Agilent (A), Olympus (OCPNY), F5 (FFIV), Jones Lang LaSalle (JLL), and United Therapeutics (UTHR), which are down more than 10% in…

StockNews.com

Scoop Up These 3 Must-Own Tech Stocks Down More Than 15% in 2022

Tech stocks have suffered a sell-off on concerns over forthcoming interest rate hikes and rising geopolitical tensions. However, rapid digitization, growing tech spending by enterprises, and continuing innovation should drive the tech sector's growth. So, we think the recent price dips could be an opportune time to bet on the…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Forget Palantir, Buy These 3 Software Stocks Instead

The shares of software provider Palantir Technologies (PLTR) have been losing momentum over the past year due to the company’s negative profit margins despite its having been in the software business for more than 17 years. However, as global software demand amps up amid the heightened adoption of hybrid working…

StockNews.com

Should You Buy the Dip in F5 Networks?

F5 Inc. (FFIV) has made consistent product and services advances and expanded its market reach over the past months. So, let's evaluate if it would be wise to buy the dip in the stock now? Read on.

StockNews.com

1 2 3

Organisations

Agilent Technologies Inc

21 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.